Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03972488
Title Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET (NETTER-2)
Acronym NETTER-2
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Advanced Accelerator Applications
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN

Facility Status City State Zip Country Details
Yale Cancer Center New Haven Connecticut 06520 United States Details
USF - H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
University of Iowa Hospitals and Clinics - Oncology Iowa City Iowa 52242 United States Details
University of Kentucky UK Markey Cancer Center Lexington Kentucky 40536 United States Details
Mayo Clinic - Oncology Rochester Minnesota 55905 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
London Health Sciences Centre, University of Western Ontario - Oncology London Canada Details
Centre Hospitalier Universitaire de Quebec Quebec Canada Details
Sunnybrook Health Sciences Centre Toronto Canada Details
BC Cancer Agency Vancouver Canada Details
CHU Paris Nord-Val de Seine Clichy France Details
Hospices Civils de Lyon (HCL) - Hopital Edouard Herriot Lyon France Details
Institut du Cancer de Montpellier - Oncology Montpellier France Details
CHU-Hôtel Dieu Service de Médecine Nucléaire Nantes France Details
Institut Gustave Roussy Villejuif France Details
Universitätsklinikum Erlangen Erlangen Germany Details
Universitätsklinikum Essen - Klinik für Nuklearmedizin Essen Germany Details
A.O.di Bologna Policl.S.Orsola Bologna Italy Details
University of Genova - Oncology Genova Italy Details
Istituto Oncologico Romagnolo Meldola Italy Details
Fondazione Irccs Istituto Nazionale Tumori Milano Italy Details
Ieo, Irccs Milano Italy Details
IRCCS fondazione Pascale - Oncology Napoli Italy Details
Arcispedale Santa Maria Nuova, Reggio Emilia - Oncology Reggio Emilia Italy Details
Azienda Ospedaliera Sant'Andrea - Università La Sapienza U.O.C. Mal App. Digerente e - Oncology Roma Italy Details
Seoul National University Bundang Hospital Seongnam-Si Korea, Republic of Details
Asan Medical Center - Oncology Seoul Korea, Republic of Details
Seoul National University Hospital - Department of Internal Medicine Seoul Korea, Republic of Details
Severance Hospital, Yonsei University Health System - Medical Oncology Seoul Korea, Republic of Details
Erasmus Medisch Centrum Rotterdam Netherlands Details
UMC Utrecht - Oncology Utrecht Netherlands Details
Hospital Universitario Vall d'Hebrón Barcelona Spain Details
Hospital General Universitario Gregorio Marañón Madrid Spain Details
Hospital Universitario Ramón y Cajal Madrid Spain Details
Hospital Universitari i Politecnic La Fe Valencia Spain Details
Bristol Haematology and Oncology Centre Bristol United Kingdom Details
Guys And St Thomas Hospital London United Kingdom Details
Kings College Hospital - Oncology London United Kingdom Details
Royal Free Hospital, London London United Kingdom Details
Weston Park Hospital Sheffield United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field